Join the Prostate Cancer group to help and get support from people like you.
Prostate Cancer News (Page 2)
Related terms: Cancer, Prostate, Carcinoma of Prostate
Acupuncture May Alleviate Nocturia in Men Treated for Prostate Cancer
TUESDAY, June 3, 2025 – Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May 29 in JAMA Oncology. Kevin T. Liou, M.D., from ...
Biden’s Prostate Cancer Likely Grew Undetected for Years, Experts Say
FRIDAY, May 23, 2025 — Former President Joe Biden's prostate cancer diagnosis has drawn attention to screening guidelines for older men. When Biden, 82, was diagnosed last week, his cancer had al...
Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy
TUESDAY, May 20, 2025 – Post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is well tolerated, with patient-reported outcomes (PROs) comparable to those seen after...
Former President Joe Biden Diagnosed With Aggressive Prostate Cancer
MONDAY, May 19, 2025 — Former President Joe Biden has been diagnosed with advanced prostate cancer that has spread to his bones, his office announced Sunday. Doctors found the cancer after Biden r...
MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
MONDAY, May 19, 2025 – Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer, according to a study...
Improvements In Prostate Cancer Tracking Help Men Stay In Active Surveillance
THURSDAY, May 15, 2025 — Men in “watchful waiting” mode for their low-risk prostate cancer are staying healthier longer thanks to advanced imaging and treatments designed to keep their tumor at bay, a...
Since 2010, Fewer Prostatectomies Being Performed for Lowest-Risk Prostate Cancer
TUESDAY, May 13, 2025 – Since 2010, there has been a decrease in the proportion of prostatectomies that are pathologic grade group 1 (pGG1), according to a study published online April 28 in JAMA...
Worried About Prostate Cancer Screening? New Study Shows Better Judgment In Treatment
THURSDAY, May 8, 2025 – Some men would rather skip screening for prostate cancer due to fears that they’ll be rendered impotent or incontinent from cancer surgery. But new research says those fears a...
Ultra-Hypofractionated Radiotherapy Noninferior for Prostate Cancer
THURSDAY, May 8, 2025 – Ultra-hypofractionated (UHF) radiotherapy delivered over two weeks is noninferior to conventionally fractionated (CF) radiotherapy delivered over eight weeks for localized...
MicroRNA-Based Germline Signature Predicts RT-Induced Genitourinary Toxicity in Prostate Cancer
FRIDAY, April 18, 2025 – A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in...
Gene Test Predicts Urinary Problems From Prostate Cancer Radiation Therapy
WEDNESDAY, April 16, 2025 – Radiation therapy is commonly used to treat prostate cancer, but it can cause embarrassing urinary problems in some men. But a new genetic test appears capable of sussing...
Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score
MONDAY, April 14, 2025 – A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according...
NeuroSAFE Improves Erectile Function After Radical Prostatectomy
THURSDAY, April 3, 2025 – Use of the NeuroSAFE technique, a standardized frozen section analysis that enables accurate real-time detection of positive surgical margins during nerve sparing in...
Similar Efficacy Seen for Isodose, Dose-Escalated MHFRT, CFRT in Prostate Cancer
TUESDAY, April 1, 2025 – For patients with prostate cancer, isodose and dose-escalated moderately hypofractionated radiotherapy (MHFRT) have similar efficacy as conventionally fractionated...
FDA Approves Novartis Radioligand Therapy Pluvicto for Earlier Use Before Chemotherapy in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate-specific membrane a...
Further information
Related condition support groups
Related drug support groups
Lupron, Lupron Depot, estradiol, Premarin, Estrace, Xtandi, docetaxel, Zytiga